China NT Pharma Group Company Limited provided group earnings guidance for the six months ended June 30, 2015. For the six months, the company announced that based on the preliminary assessment of the unaudited consolidated management accounts of the company for the six months ended 30 June 2015, the group expects to record a substantial increase in net profit by more than 1,400% for the six months ended 30 June 2015 as compared to the same period of 2014. Such increase is primarily attributable to the significant improvement of gross profit margin of its proprietary products and decrease of finance cost.